Search clinical trials for: Androgen Receptor Antagonist ARN-509
Total 11767 results
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
-
Enzon Pharmaceuticals, Inc.SuspendedProstatic NeoplasmUnited States, United Kingdom
-
Janssen Research & Development, LLCActive, not recruiting
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
Bristol-Myers SquibbCompletedProstate CancerUnited States
-
Aragon Pharmaceuticals, Inc.Active, not recruiting
-
Medical University of South CarolinaTerminatedProstate CancerUnited States
-
Aragon Pharmaceuticals, Inc.Completed
-
Andrew J. Armstrong, MDCompleted
-
European Organisation for Research and Treatment...Withdrawn
-
Banaras Hindu UniversityCompleted
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Prostate Carcinoma Metastatic to the BoneUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR)CompletedProstate CancerUnited States
-
Karin SoderkvistKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; Region... and other collaboratorsRecruitingProstate Cancer Metastatic | Positron-Emission Tomography | Radiation TherapySweden
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Cancer Research SocietyRecruitingNon-Muscle Invasive Bladder CancerCanada
-
Rahul AggarwalJanssen Scientific Affairs, LLCActive, not recruitingProstate Cancer | Small Cell Carcinoma | Small Cell Neuroendocrine CarcinomaUnited States
-
AndroScience CorpCompleted
-
University of Colorado, DenverRecruitingHypertension | Prostate Cancer | Autonomic Dysfunction | Androgen Deprivation Therapy | Renal DiseaseUnited States
-
Janssen Research & Development, LLCCompleted
-
Abdenour NabidAstraZenecaActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage IIB Prostate Cancer AJCC v8United States
-
Institut Paoli-CalmettesJanssen-Cilag Ltd.UnknownLow Risk Prostate CancerFrance
-
Astellas Pharma IncPfizerCompleted
-
Aragon Pharmaceuticals, Inc.Completed
-
University of WashingtonNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCTerminatedProstate AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteJanssen PharmaceuticaActive, not recruitingProstate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingStage II Prostate Adenocarcinoma | Stage III Prostate AdenocarcinomaUnited States
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingProstate Cancer | Neoadjuvant Therapy | Prostatectomy | Androgen AntagonistsBelgium
-
University of MiamiVarian Medical SystemsRecruiting
-
Ain Shams UniversityUnknown
-
University Hospital Inselspital, BerneCompleted
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCRecruitingProstate Cancer | Prostatectomy | Androgen Axis SuppressionUnited States
-
Dr. Tamim NiaziAbbVie (prior sponsor, Abbott)CompletedAdjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma ProstateAdenocarcinoma of the ProstateCanada
-
Mayo ClinicNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAging | Low DHEA for Women | Low Testosterone and DHEA for MenUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
National Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
University of ChicagoRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...BayerRecruitingProstate Adenocarcinoma | Metastatic Prostate Adenocarcinoma | Castration-resistantUnited States, Brazil
-
European Institute of OncologyRecruitingOligometastatic Prostate CancerItaly
-
University of California, IrvineApplied Biology, Inc.WithdrawnCovid19 | Androgen Receptor Gene OverexpressionUnited States
-
VA Greater Los Angeles Healthcare SystemActive, not recruiting
-
Sohag UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterFerring PharmaceuticalsCompletedProstate Cancer | Prostatic AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterExelixis; High Impact Clinical Research Support ProgramCompletedProstate CancerUnited States
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Canada, China, Poland, Brazil
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Active, not recruiting